GB
Blanchard Rohner, Géraldine
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Reply to Hinpetch Daungsupawong | Pediatric allergy and immunology | 2025 | 10 | 0 | |||
Vaccine immunity in patients with 22q11.2 microdeletion syndrome | Pediatric allergy and immunology | 2025 | 48 | 2 | |||
Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins : 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial | EClinicalMedicine | 2024 | 43 | 32 | |||
Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children : The potential role of prior natural infection | Pediatric allergy and immunology | 2024 | 94 | 82 | |||
Vaccine immunity in children after hematologic cancer treatment : a retrospective single-center study | Journal of pediatric hematology/oncology | 2024 | 34 | 23 | |||
One-year longitudinal study of antibody profiles in children : MIS-C versus children with uncomplicated COVID-19 | The Pediatric infectious disease journal | 2024 | 38 | 54 | |||
Assessing vaccine-induced immunity against pneumococcus, hepatitis A and B over a 9-year follow-up in pediatric liver transplant recipients : A nationwide retrospective study | American journal of transplantation | 2024 | 66 | 26 | |||
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children | Science | 2023 | 49 | 13 | |||
Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonates | Clinical infectious diseases | 2023 | 60 | 66 | |||
Utilité clinique des genome boards pour les maladies génétiques complexes | Revue médicale suisse | 2023 | 146 | 37 | |||
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19 | Frontiers in immunology | 2023 | 175 | 32 | |||
Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease | The journal of experimental medicine | 2023 | 38 | 11 | |||
Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) : an open-label, multicentre, randomised trial | The Lancet. Child & adolescent health | 2023 | 34 | 24 | |||
Hyper-IgE syndrome presenting with early life craniosynostosis in monozygotic twin sisters | Pediatric allergy and immunology | 2023 | 92 | 46 | |||
Autoantibodies to a nodal isoform of neurofascin in pediatric chronic inflammatory demyelinating polyneuropathy | Child neurology open | 2023 | 17 | 23 | |||
Quelles pathologies immunologiques sont ciblées par la médecine de précision ? | Revue médicale suisse | 2023 | 27 | 9 | |||
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 | Genome medicine | 2023 | 42 | 11 | |||
Vaccination of immunosuppressed children in clinical practice | 2022 | 36 | 0 | ||||
Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19 | Journal of molecular medicine | 2022 | 60 | 29 | |||
Acceptability of COVID-19 Vaccine Among Hospital Employees in the Department of Paediatrics, Gynaecology and Obstetrics in the University Hospitals of Geneva, Switzerland | Frontiers in public health | 2022 | 88 | 63 | |||
Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant Forms | Frontiers in immunology | 2022 | 256 | 106 | |||
Novel approaches to reactivate pertussis immunity | Expert review of vaccines | 2022 | 140 | 168 | |||
Evaluation of rotavirus vaccine administration among a 22q11.2DS patient population | Allergy, asthma, and clinical immunology | 2022 | 120 | 67 | |||
Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome — Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial | Frontiers in pediatrics | 2022 | 186 | 54 | |||
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | 2022 | 172 | 122 | |||
Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical Guide | Frontiers in immunology | 2021 | 262 | 127 | |||
Maladies infectieuses | Revue médicale suisse | 2021 | 357 | 92 | |||
Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland | Frontiers in pediatrics | 2021 | 65 | 36 | |||
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity | Cell reports | 2021 | 390 | 209 | |||
Meningitis Caused by the Live Varicella Vaccine Virus: Metagenomic Next Generation Sequencing, Immunology Exome Sequencing and Cytokine Multiplex Profiling | Viruses | 2021 | 188 | 135 | |||
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms | Journal of clinical immunology | 2021 | 270 | 102 | |||
X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children - A Case Report | Frontiers in pediatrics | 2021 | 71 | 41 | |||
Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19 | Journal of the Pediatric Infectious Diseases Society | 2021 | 295 | 42 | |||
Case report: case series of children with multisystem inflammatory syndrome following SARS-CoV-2 infection in Switzerland | Frontiers in pediatrics | 2021 | 160 | 97 | |||
Pediatric Acute B-Cell Lymphoblastic Leukemia Developing Following Recent SARS-CoV-2 Infection | Journal of pediatric hematology/oncology | 2021 | 219 | 0 | |||
Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT | Frontiers in immunology | 2021 | 238 | 104 | |||
Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipients | Vaccine | 2021 | 193 | 0 | |||
Pediatric COVID-19: Immunopathogenesis, Transmission and Prevention | Vaccines | 2021 | 201 | 72 | |||
Vaccination in immunosuppressed children: a comprehensive review and practical guide | 2020 | 413 | 4 | ||||
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial | Clinical Microbiology and Infection | 2020 | 274 | 133 | |||
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19) | Clinical Infectious Diseases | 2020 | 446 | 281 | |||
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere | 2020 | 491 | 185 | |||
Optimal timing of influenza vaccine during pregnancy: A systematic review and meta-analysis | Influenza and other Respiratory Viruses | 2019 | 248 | 139 | |||
Usefulness of a systematic approach at listing for vaccine prevention in solid organ transplant candidates | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2019 | 403 | 3 | |||
Germline CBM-opathies: From immunodeficiency to atopy | Journal of Allergy and Clinical Immunology | 2019 | 220 | 0 | |||
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial | Clinical Infectious Diseases | 2019 | 281 | 286 | |||
A 19-month-old boy with refractory cervical adenitis | Pediatric Infectious Disease Journal | 2019 | 357 | 1 | |||
Activated Phosphoinositide 3 Kinase Delta Syndrome (APDS): A Primary Immunodeficiency Mimicking Lymphoma | Journal of Pediatric Hematology / Oncology | 2018 | 461 | 1 | |||
Review of maternal immunisation during pregnancy: focus on pertussis and influenza | Swiss Medical Weekly | 2017 | 329 | 131 | |||
Parler vaccination aux parents : un défi pour le médecin de premier recours | Revue médicale suisse | 2017 | 339 | 104 | |||
Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal Immunization | Clinical Infectious Diseases | 2017 | 597 | 232 | |||
Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis | Clinical infectious diseases | 2016 | 706 | 5 | |||
Impact de la vaccination sur les otites moyennes aiguës | Revue médicale suisse | 2016 | 402 | 1 | |||
Awareness of Cytomegalovirus Infection among Pregnant Women in Geneva, Switzerland: A Cross-sectional Study | International journal of environmental research and public health | 2015 | 670 | 279 | |||
Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom | Clinical and vaccine immunology | 2014 | 544 | 0 | |||
Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom | Pediatric Infectious Disease Journal | 2013 | 148 | 0 | |||
The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age | Vaccine | 2013 | 401 | 195 | |||
Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn | The Pediatric infectious disease journal | 2013 | 701 | 3 | |||
Acceptability of maternal immunization against influenza: the critical role of obstetricians | Journal of maternal-fetal & neonatal medicine | 2012 | 701 | 0 | |||
Vaccination against seasonal flu in Switzerland: The indecision of pregnant women encouraged by healthcare professionals | Revue d'épidémiologie et de santé publique | 2012 | 697 | 3 | |||
Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine | Vaccine | 2012 | 190 | 181 | |||
Vaccination during pregnancy to protect infants against influenza: why and why not? | Vaccine | 2011 | 589 | 0 | |||
Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy | Expert Review of Vaccines | 2011 | 157 | 0 | |||
Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children | Journal of Immunological Methods | 2010 | 150 | 0 | |||
Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine | Immunology | 2009 | 150 | 140 | |||
Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans | Blood | 2009 | 201 | 183 | |||
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response | The Journal of immunology | 2008 | 580 | 2 | |||
Sustaining immunity after immunization against encapsulated bacteria | Human Vaccines | 2008 | 167 | 0 | |||
Persistence of protection against invasive bacteria-memory b cell response in infants after immunisation | 2008 | 315 | 1 | ||||
Une étude de la réponse des cellules B mémoires au vaccin polysaccharidique conjugué contre le méningocoque du sérogroupe C | 2006 | 1,028 | 441 |